BioVaxys

Last updated: October 28, 2025
Founders: Kenneth Kovan, David Berd
Founders: Kenneth Kovan, David Berd
Country: USA | Funding: $13.8M (+)

Website: https://biovaxys.com/

BioVaxys is a clinical stage biotechnology company developing immunotherapeutic cancer vaccines targeting melanoma and ovarian cancer.




Competitors